GSK CEO addresses declining trust in vaccines following Trump re-election
GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to gauge impact.
Strong Wegovy revenue growth for Novo Nordisk but shares dip
Trump triumphs but impact on healthcare industry remains unclear
GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
Intra-Cellular bolsters Caplyta data with another Phase III win
Zentiva voices UWWTD concerns as EU grants approval
Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals
Tevogen Bio partners Microsoft for HPV treatment
Analysis
View More
Themes
View MoreFDA approves Journey Medical’s rosacea treatment Emrosi
Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
Leading clinical trials companies in the artificial intelligence theme
Q2 2024 update: electronic medical record (emr) systems related private equity activity in the pharmaceutical industry
CMN-005 by CoImmune for Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma): Likelihood of Approval
More Insights
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
NCCN visits Vietnam in continued cancer care collaboration
Reeves’ 2024 budget promises life sciences investment
UPFs fuelling ‘alarming rise of chronic diseases’ in india
Pharma companies must adapt to keep pace with AI developments, say experts